[HTML][HTML] Machine learning in the prediction of cancer therapy

R Rafique, SMR Islam, JU Kazi - Computational and Structural …, 2021 - Elsevier
Resistance to therapy remains a major cause of cancer treatment failures, resulting in many
cancer-related deaths. Resistance can occur at any time during the treatment, even at the …

Precision medicine and driver mutations: computational methods, functional assays and conformational principles for interpreting cancer drivers

R Nussinov, H Jang, CJ Tsai… - PLoS computational …, 2019 - journals.plos.org
At the root of the so-called precision medicine or precision oncology, which is our focus
here, is the hypothesis that cancer treatment would be considerably better if therapies were …

[HTML][HTML] Conserved pan-cancer microenvironment subtypes predict response to immunotherapy

A Bagaev, N Kotlov, K Nomie, V Svekolkin, A Gafurov… - Cancer cell, 2021 - cell.com
The clinical use of molecular targeted therapy is rapidly evolving but has primarily focused
on genomic alterations. Transcriptomic analysis offers an opportunity to dissect the …

DeepProg: an ensemble of deep-learning and machine-learning models for prognosis prediction using multi-omics data

OB Poirion, Z Jing, K Chaudhary, S Huang… - Genome medicine, 2021 - Springer
Multi-omics data are good resources for prognosis and survival prediction; however, these
are difficult to integrate computationally. We introduce DeepProg, a novel ensemble …

[HTML][HTML] Cancer modeling: From mechanistic to data-driven approaches, and from fundamental insights to clinical applications

S Bekisz, L Geris - Journal of Computational Science, 2020 - Elsevier
Cancer is still one of the major causes of death worldwide. Even if its comprehension is
improving continuously, the complexity and heterogeneity of this group of diseases …

Application of non-negative matrix factorization in oncology: one approach for establishing precision medicine

R Hamamoto, K Takasawa, H Machino… - Briefings in …, 2022 - academic.oup.com
The increase in the expectations of artificial intelligence (AI) technology has led to machine
learning technology being actively used in the medical field. Non-negative matrix …

[HTML][HTML] A scalable high-throughput targeted next-generation sequencing assay for comprehensive genomic profiling of solid tumors

JM Conroy, S Pabla, ST Glenn, RJ Seager… - PLoS …, 2021 - journals.plos.org
Timely and accurate identification of molecular alterations in solid tumors is essential for
proper management of patients with advanced cancers. This has created a need for rapid …

5-Methylcytosine RNA methyltransferases-related long non-coding RNA to develop and validate biochemical recurrence signature in prostate cancer

K Wang, W Zhong, Z Long, Y Guo, C Zhong… - Frontiers in molecular …, 2021 - frontiersin.org
The effects of 5-methylcytosine in RNA (m5C) in various human cancers have been
increasingly studied recently; however, the m5C regulator signature in prostate cancer …

Personalized clinical decision making through implementation of a molecular tumor board: a German single-center experience

R Hoefflin, AL Geißler, R Fritsch, R Claus… - JCO Precision …, 2018 - ascopubs.org
Purpose Dramatic advances in our understanding of the molecular pathophysiology of
cancer, along with a rapidly expanding portfolio of molecular targeted drugs, have led to a …

Precision medicine informatics: principles, prospects, and challenges

M Afzal, SMR Islam, M Hussain, S Lee - IEEE Access, 2020 - ieeexplore.ieee.org
Precision medicine (PM) is an emerging approach that appears with the impression of
changing the existing paradigm of medical practice. Recent advances in technological …